Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012484 |
---|---|
Receipt number | R000014616 |
Scientific Title | Sorafenib vs. half dose Sorafenib and UFT combined therapy in patients with Hepatocellular carcinoma refractory to TACE: Randamized Prospective Study |
Date of disclosure of the study information | 2013/12/09 |
Last modified on | 2016/01/11 16:05:55 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/12/04 10:41:29 | ||
2 | Update | 2013/12/18 11:23:04 | Key secondary outcomes |
|
3 | Update | 2013/12/18 12:48:11 | Key inclusion criteria |
|
4 | Update | 2013/12/18 12:57:12 | Key exclusion criteria Key exclusion criteria |
|
5 | Update | 2013/12/18 13:03:49 | Organization Division name Name of person sending information Organization Division name Division name Address Institute Organization Co-sponsor Institutions |
|
6 | Update | 2014/02/13 20:33:33 | Public title Acronym |
|
7 | Update | 2014/02/13 20:37:27 | Recruitment status |
|
8 | Update | 2016/01/11 16:05:55 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information |